LDLR and central nervous system cancer: This cholesterol hypersecretion coincides with reduced tumoral cholesterol retention, driven by epigenetic modulation of the miR-19a/LDLR axis alongside ABCA1 upregulation and LDLR suppression, collectively impairing proliferation and invasion in gliomas [63].